|
Report Date : |
13.02.2013 |
IDENTIFICATION DETAILS
|
Name : |
LG LIFE SCIENCES LTD. |
|
|
|
|
Registered Office : |
LG Kwangwhamun Bldg.92, Sinmunno 2-ga, Jongno-gu, Seoul, Korea 110-062 |
|
|
|
|
Country : |
South Korea |
|
|
|
|
Financials (as on) : |
30.09.2012 |
|
|
|
|
Date of Incorporation : |
02.08.2002 |
|
|
|
|
Com. Reg. No.: |
107-86-21066 |
|
|
|
|
Legal Form : |
Listed Company |
|
|
|
|
Line of Business : |
Manufacture of Finished Medicaments |
|
|
|
|
No. of Employees : |
1,435 |
RATING & COMMENTS
|
MIRA’s Rating : |
A |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Status : |
Good |
|
Payment Behaviour : |
Regular |
|
Litigation : |
Exist |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2011) |
Current Rating (30.06.2012) |
|
South Korea |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SOUTH KOREA - ECONOMIC OVERVIEW
South Korea over the past four decades has demonstrated incredible growth and global integration to become a high-tech industrialized economy. In the 1960s, GDP per capita was comparable with levels in the poorer countries of Africa and Asia. In 2004, South Korea joined the trillion dollar club of world economies, and currently is among the world's 20 largest economies. Initially, a system of close government and business ties, including directed credit and import restrictions, made this success possible. The government promoted the import of raw materials and technology at the expense of consumer goods, and encouraged savings and investment over consumption. The Asian financial crisis of 1997-98 exposed longstanding weaknesses in South Korea''s development model including high debt/equity ratios and massive short-term foreign borrowing. GDP plunged by 6.9% in 1998, and then recovered by 9% in 1999-2000. Korea adopted numerous economic reforms following the crisis, including greater openness to foreign investment and imports. Growth moderated to about 4% annually between 2003 and 2007. With the global economic downturn in late 2008, South Korean GDP growth slowed to 0.3% in 2009. In the third quarter of 2009, the economy began to recover, in large part due to export growth, low interest rates, and an expansionary fiscal policy, and growth was 3.6% in 2011. In 2011, the US-South Korea Free Trade Agreement was ratified by both governments and is projected to go into effect in early 2012. The South Korean economy''s long term challenges include a rapidly aging population, inflexible labor market, and heavy reliance on exports - which comprise half of GDP.
Source
: CIA
|
Company
Name |
LG LIFE SCIENCES LTD. (Korean Company Name : “(주)LG생명과학”) |
|
Registered Address |
92, Sinmunno 2-ga, Jongno-gu, Seoul, Korea |
|
Building |
LG Kwangwhamun Bldg. |
|
Zip Code |
110-062 |
|
Tel |
+82-2-3773-1114 |
|
Fax |
+82-2-3773-7012 |
|
E-mail |
webmaster@lgls.co.kr |
|
Website |
www.lgls.co.kr |
|
Trading Address |
LG Kwangwhamun Bldg., 92, Sinmunno 2-ga,
Jongno-gu, Seoul, Korea |
|
Tel |
+82-2-3773-1114 |
|
Fax |
+82-2-3773-3176 |
|
Other Address |
104-1, Munji-dong, Yuseong-gu, Daejeon,
Korea |
|
Tel |
+82-42-866-2114 |
|
Fax |
+82-42-862-0332 |
|
Other Address |
580, Hwasan-ri, Onsan-eup, Ulju-gun, Ulsan, Korea |
|
Tel |
+82-52-231-5324 |
|
Fax |
+82-52-231-5328 |
|
Other Address |
601, Yongje-dong, Iksan-si, Jeollabuk-do,
Korea |
|
Tel |
+82-63-830-4777 |
|
Fax |
+82-63-830-4204 |
|
Type |
Export |
|
Industry |
Manufacture of Finished Medicaments |
|
Main Business |
Hepatitis-B Vaccine, Gemifloxacin, Human Growth Hormone, Supplementary
Agents, High-Blood Pressure Medicines, General Anemia Medicines, Acyesis
Treatments, Myalgia Treatments, Hepatitis Diagnostics, Endocrine Treatment,
Anti-Infective Treatment, Oncolgy Acid Product, Inferuronic Treatment
Cardiovascular Treatment |
|
Established (mm/dd/yyyy) |
08/02/2002 |
|
Activity |
Detailed Products (UNSPSC) |
|
Sell |
Hepatitis B virus vaccine(51201607) |
|
Sell |
Herbicides(10171700) |
|
Sell |
Antineoplastic agents(51110000) |
|
Sell |
Influenza virus vaccine(51201608) |
|
Sell |
Veterinary nutritional supplement(51250000) |
|
Sell |
Antihypertensive drugs(51121700) |
|
Sell |
Dietary supplements and nutritional therapy
products(51191900) |
|
Sell |
Veterinary antibiotics(51102600) |
|
Sell |
Immunology analyzer accessories or
supplies(41115820) |
|
Sell |
Antihypertensive drugs(51121700) |
|
Sell |
Nonsteroidal anti inflammatory drugs
NSAIDs(51142100) |
|
Sell |
Growth hormones and their
inhibitors(51182300) |
|
Sell |
Calcium salts and calcium regulators(51182400) |
|
Sell |
Thrombolytic drugs and platelet aggregation
inhibitors(51131700) |
|
Sell |
Gonadotropic hormones and ovarian stimulants
and inhibitors(51181900) |
|
Sell |
Livestock feed(10121500) |
|
Sell |
Metabolites(51251000) |
|
Sell |
Centrally acting skeletal muscle
relaxants(51151900) |
|
Name |
Jung Il-Jae |
|
Address |
|
|
Date of Birth |
01/30/1959 |
|
Title |
President & CEO |
|
Sex |
Male |
|
Nationality |
Korean |
|
Capital (KRW) |
84,066,030,000 |
|||||||||||||||||||||
|
Employees |
1,435 |
|||||||||||||||||||||
|
Formation |
Listed Company (Korea Stock Exchange:
068870) as of 08/16/2002 A Company of LG Business Group |
|||||||||||||||||||||
|
Bank Details |
Woori Bank- Twin Tower
Branch Shinhan Bank-Yeoido Branch 45-11, Yoidodong, Yongdeungpo-gu, Seoul,
Korea |
|||||||||||||||||||||
|
Corporate Registered No. |
110111-2581183 |
|||||||||||||||||||||
|
Business Registered No. |
107-86-21066 |
|||||||||||||||||||||
|
Permit & Licenses |
Int’l Trade No.: 45034471 |
|||||||||||||||||||||
|
Shareholder Position |
|
|||||||||||||||||||||
|
Company History |
08/02/2002 Incorporated as the present name
after
being spun off from LGCI 09/17/2010 Moved to the present HQ address from LG Twin Tower, 20, Yeouido-dong,
Yeongdeungpo-gu, Seoul, Korea |
|||||||||||||||||||||
|
|
|
|
Job Description |
Title |
Name |
Nationality |
Date of Birth |
Education |
|
President & CEO |
Mr. |
Jung Il-Jae |
Korean |
1959.01.30 |
- |
|
Executive Director & CFO |
Mr. |
Lee Jong-Hee |
Korean |
1958.04.15 |
Dongah University, Korea |
|
Director |
Mr. |
Kim Ju-Hyung |
Korean |
1955.07.03 |
Seoul National University, Korea |
|
Director |
Mr. |
You Ji-Young |
Korean |
1962.10.02 |
- |
|
Outside Director /Auditor |
Mr. |
Shim Chang-Koo |
Korean |
1948.07.21 |
Tokyo University, Japan |
|
Outside Director /Auditor |
Mr. |
Lee Chul |
Korean |
1949.07.08 |
- |
|
Outside Director /Auditor |
Mr. |
Sohn Bok-Jo |
Korean |
1951.07.09 |
- |
|
Year / Unit : KRW |
Sales |
Assets |
Net Income |
|
277,863,221,157 |
507,659,423,542 |
4,974,433,034 |
|
|
(*)2010 |
334,341,284,611 |
402,281,401,713 |
16,439,355,348 |
|
(*)2009 |
327,257,789,712 |
372,378,590,622 |
21,669,273,326 |
|
2008 |
281,891,466,398 |
388,028,687,257 |
15,164,003,885 |
|
2007 |
256,402,534,934 |
409,948,588,797 |
18,546,130,912 |
|
2006 |
221,204,651,923 |
389,359,069,138 |
5,930,494,927 |
|
2005 |
213,252,354,218 |
383,329,657,204 |
(-)923,963,402 |
|
2004 |
213,636,024,824 |
396,471,198,545 |
10,073,423,277 |
|
2003 |
179,037,402,211 |
340,667,437,918 |
3,011,089,070 |
(*)Figures are based
on the K-IFRS Accounting System.
|
Authorized Capital(KRW) |
190,000,000,000 |
|
Paid-Up Capital(KRW) |
84,066,030,000 |
|
Total Issues Shares |
16,813,206(Common : 16,576,990 Preferable :236,216) |
Balance
Sheet
|
|||
|
Unit : Korean Won |
01/01/2012~09/30/2012 |
As of 12/31/2011 |
As of 12/31/2010 |
|
Total
Assets |
541,961,735,506 |
497,386,882,756 |
402,281,401,713 |
|
Current Assets |
244,711,955,165 |
216,471,589,255 |
173,709,915,647 |
|
Cash
& Cash Equivalents |
58,352,984,967 |
44,379,541,577 |
21,035,940,778 |
|
Derivatives |
162,713 |
101,073,449 |
|
|
Trade
Receivables |
84,243,154,307 |
89,775,511,800 |
80,806,869,573 |
|
Other
Receivables |
3,162,449,638 |
1,850,076,644 |
1,351,303,750 |
|
Other
Finance Assets |
969,582,308 |
3,534,344,873 |
10,345,071,802 |
|
Other Current Assets |
1,682,209,667 |
870,856,289 |
1,413,165,890 |
|
Deferred
Income Tax Assets |
277,891,835 |
222,139,448 |
438,324,420 |
|
Inventories |
96,023,519,730 |
75,738,045,175 |
58,319,239,434 |
|
Non-Current Assets |
297,249,780,341 |
280,915,293,501 |
228,571,486,066 |
|
Finance
Assets |
81,175,297 |
81,175,297 |
222,993,999 |
|
Other
Receivables |
1,490,712,415 |
1,496,693,922 |
|
|
Marketable
Financial Instruments |
1,264,298,638 |
1,264,298,638 |
1,264,298,638 |
|
Investment_Subsidiaries |
2,752,043,759 |
2,752,043,759 |
2,356,088,759 |
|
Other
Finance Assets |
7,768,181,777 |
5,136,472,321 |
8,619,443,191 |
|
Deferred Income Taxes |
30,305,082,752 |
26,718,313,482 |
23,451,415,023 |
|
Tangibles |
225,885,945,492 |
217,474,868,604 |
172,925,368,268 |
|
Intangibles |
27,702,340,211 |
25,991,427,478 |
19,731,878,188 |
|
Total
Liabilities |
300,965,887,370 |
250,428,702,874 |
156,572,674,920 |
|
Current Liabilities |
99,223,838,740 |
96,131,441,135 |
105,073,719,585 |
|
Trade
Payables |
43,185,643,417 |
33,006,606,950 |
18,311,232,859 |
|
Other
Payables |
17,585,368,340 |
20,241,047,952 |
17,895,321,915 |
|
Borrowings |
23,486,069,030 |
27,691,232,257 |
58,363,922,547 |
|
Other
Financial Debts |
7,191,222,846 |
4,954,250,885 |
4,806,572,462 |
|
Other Provisions |
1,143,630,998 |
1,100,625,603 |
839,312,436 |
|
Other Current Liabilities |
6,631,904,109 |
9,137,677,488 |
4,857,357,366 |
|
Non-Current Liabilities |
201,742,048,630 |
154,297,261,739 |
51,498,955,335 |
|
Borrowings |
178,262,955,320 |
135,700,335,582 |
39,100,000,000 |
|
Other Financial Debts |
4,278,342,269 |
4,774,686,111 |
5,849,656,797 |
|
Provision for Severance & Retirement |
16,127,522,216 |
10,551,189,718 |
3,494,725,624 |
|
Other Provisions |
3,073,228,825 |
3,271,050,328 |
3,054,572,914 |
|
Capital
Stock |
84,066,030,000 |
84,066,030,000 |
84,066,030,000 |
|
Capital
Surplus |
147,045,545,174 |
147,045,545,174 |
147,045,545,174 |
|
Profit
Surplus |
9,884,539,362 |
15,846,871,108 |
14,597,418,019 |
|
Others |
-266,400 |
-266,400 |
-266,400 |
|
Total
Equity |
240,995,848,136 |
246,958,179,882 |
245,708,726,793 |
|
Liab.
& Shareholder’s Equity |
541,961,735,506 |
497,386,882,756 |
402,281,401,713 |
Income
Statement
|
|||
|
Unit : Korean Won |
01/01/2012~09/30/2012 |
As of 12/31/2011 |
As of 12/31/2010 |
|
Sales |
274,561,235,451 |
372,487,090,281 |
334,341,284,611 |
|
Cost of Sold Goods |
157,262,402,018 |
212,757,444,868 |
179,044,644,774 |
|
Gross Profit |
117,298,833,433 |
159,729,645,413 |
155,296,639,837 |
|
Other Operating Income |
6,813,423,067 |
11,121,596,045 |
14,603,589,103 |
|
Selling & Admin. Expenses |
120,904,054,470 |
153,455,470,926 |
144,323,248,424 |
|
Other Operating Income |
3,445,712,309 |
6,590,294,150 |
5,999,780,502 |
|
Operating Income |
-237,510,279 |
10,805,476,382 |
19,577,200,014 |
|
Operating Income |
2,017,568,228 |
2,165,812,922 |
1,514,521,500 |
|
Finance Income |
7,634,484,668 |
8,362,122,769 |
5,217,964,179 |
|
Finance Expenses |
-537,358,639 |
-266,926,477 |
-377,127,912 |
|
Income Before Taxes |
-6,391,785,358 |
4,342,240,058 |
15,496,629,423 |
|
Income Taxes Expenses |
-2,497,130,772 |
1,453,932,235 |
942,725,925 |
|
Net Income |
-3,894,654,586 |
5,796,172,293 |
16,439,355,348 |
Cash
Flows
|
|||
|
Unit : Korean Won |
01/01/2012~09/30/2012 |
As of 12/31/2011 |
As of 12/31/2010 |
|
Operating
Activities Cash Flows |
1,652,147,308 |
19,561,767,025 |
-5,396,439,419 |
|
Net Income |
8,054,938,775 |
25,414,532,683 |
2,377,231,516 |
|
Adjustment |
935,428,674 |
1,522,426,498 |
1,383,355,052 |
|
Changes in Asset/ & Liability |
-6,776,020,249 |
-7,060,818,886 |
-4,463,815,107 |
|
Income Taxes |
-562,199,892 |
-314,373,270 |
-4,693,210,880 |
|
Cash Flows from Investing |
-25,973,404,816 |
-61,311,606,921 |
-34,119,061,000 |
|
Cash Flows from Financing |
38,364,033,517 |
65,093,440,695 |
38,240,184,490 |
|
Increase/Decrease in Cash |
13,973,443,390 |
23,343,600,799 |
-1,275,315,929 |
|
Cash at the Beginning of Year |
44,379,541,577 |
21,035,940,778 |
22,311,256,707 |
|
Cash at the End of Year |
58,352,984,967 |
44,379,541,577 |
21,035,940,778 |
|
Main Products & Services |
Pharmaceuticals, Animal Health,
Pharmaceutical Intermediates, Agrochemicals |
|
Detailed Products Spec. |
1.
Pharmaceuticals: Vaccines,
Recombinant, Biological Products, Sodium Hyaluronate, Infertility Treatment,
Antibiotics, Anti-Cancer Drugs, Anti-Viral Drugs, In-Vitro Diagnostics, Raw
Materials, Antibiotics 2.
Animal Health:
Genetic Engineering Product, Antibiotics, Anthelmintic, Feed Additive 3.
Pharmaceutical
Intermediates: Aminothiazole, Cephalosporin Products (Crude), Nucleoside,
Intermediate for Anti-Fungal, Intermediate for Cilostazole, Intermediate for
radiopaque contrast media 4.
Agrochemicals:
Fungicide, Herbicide, Insecticide |
|
Technologies Acquired |
An antibiotic / the formal approval from
the U.S. Federal Drug Administration |
|
Suppliers |
RECORDATI TECHWELL FUKANG YANGNONG KAIFENG |
|
Customers |
KOREA OTSUKA PHARMACEUTICAL CO., LTD.(110111-0322597) DONGBANG AGRO CORP.(110111-0124969) HANMIFINECHEMICAL CO.,LTD.(131111-0005106) DAEHAN NEW PHARM CO., LTD.(110111-0383515) BO BOO PHARMACEUTICAL CO.,
LTD.(110111-0916572) |
|
Competitors |
YUNGJIN PHARM IND. CO., LTD. 451-20 CHEONHO 3-DONG KANGDONG-GU, SEOUL,
134-020 KOREA TEL:+82-2-20418200 FAX:+82-2-4639544 HANALL PHARMACEUTICAL CO., LTD. 400-1 SANGSEO-DONG, DAEDEOK-GU, DAEJEON,
306-120 KOREA TEL:+82-42-9325997 FAX:+82-42-9326427 CKD BIO CORPORATION 368, CHUNGJEONGRO 3-GA SEODAEMOON-GU,
SEOUL, 120-756 KOREA TEL:+82-2-21940555 FAX:+82-2-21940556 SYNGENTA BAYER MONSANTO DOW DUPONT |
(Subsidiaries,
Joint-Venture & Affiliates)
|
Affiliates-Domestic |
LG CORP.(110111-0003543) LG ELECTRONICS INC.(110111-2487050) LG CHEM LTD.(110111-2207995) LG DACOM CORPORATION(110111-0315948) LG INTERNATIONAL CORP(110111-0004632) LG CHEM LTD.(110111-2207995) LG HOUSEHOLD & HEALTH CARE
LTD.(110111-2208000) LG LIFE SCIENCES CO., LTD.(110111-2581183) LG DISPLAY CO., LTD.(110111-0393134) LG TELECOM CO., LTD.(110111-1296676) LG INNOTEK CO., LTD.(110111-0192180) LG MICRON LTD.(175311-0001075) LG DOW POLYCARBONATE CO.,
LTD.(206211-0014519) LG CNS CO., LTD.(110111-0516695) LG SPORTS CO., LTD.(110111-0359300) LG MANAGEMENT DEVELOPMENT INSTITUTE CO.,
LTD.(110111-0423494) SILTRON INCORPORATED(175311-0001348) LG MMA CORPORATION(206211-0001805) DACOM MULTIMEDIA INTERNET
CORPORATION(110111-1905441) DACOM CROSSING CORPORATION(110111-2234683) SERVEONE(110111-2411520) LG N SYS CO., LTD.(110111-2397027) HIPLAZA CO., LTD.(131111-0028801) LG POWERCOM CORPORATION(110111-1863889) HI BUSINESS LOGISTICS CO.,LTD. V-ENS CO., LTD.(120111-0334897) LUSEM CO., LTD.(176011-0038073) CS LEADER CO., LTD.(110111-2271924) AIN TELE SERVICE CO., LTD.(180111-0367581) BIZ TECH & EKTIMO CO.,
LTD.(110111-2689507) LG SOLAR ENERGY INC.(110111-3759408) COCA-COLA BEVERAGE CO.,
LTD.(110111-1342130) UCESS PARTNERS CO., LTD.(110111-3798026) SYSTEM AIR-CON ENGINEERING INCORPORATION(110111-3371989) JIHEUNG CO., LTD.(180111-0630053) CS ONE PARTNER CORPORATION(110111-3961756) SEETECH CO., LTD. TWIN WINE CO., LTD.(110111-3791129) KOREA COMMERCIAL VEHICLE CO.,
LTD.(200111-0105200) GIOVINE CO., LTD.(110111-3942714) PIXDIX CO., LTD.(110111-3947657) |
|
Affiliates-Overseas |
LG INNOTEK HUIZHOU CO.,LTD SERVEONE(NANJING) COMPANY LIMITED ARCELIC-LG KLIMA SANAYI VE TICARTE
A.S(LGEAT) BEIJING LG HOUSEHOLD CHEMICAL CO., LTD. CCKBC(NETHERLANDS)HOLDING Ⅰ BV CCKBC(NETHERLANDS)HOLDING Ⅱ BV COMPACT POWER INC. DACOM AMERICA INC. DE ZWARTE PONK B.V.(DZP) EIC PROPERTIES PTE.LTD. ELECTROMAGNETICA GOLDSTAR S.R.L EPC MUNAI LLP FOSCO B.V. GFTZ LG INTERNATIONAL LTD. GLOBAL PROFESSIONAL SOURCING CO., LTD GUANGZHOU NEW VISION TECHNOLOGY RESEARCH
AND DEVELOPMENT LIMITED HANGZHOU LG COSMETICS CO., LTD. HI LOGISTICS CHINA HI LOGISTICS EUROPE B.V. LANCHAO LG(YANTAI)DIGITAL MOBILE TECH&
DEVELOP.CO. INSPUR LG DIGITAL MOBILE COMMUNICATIONS
CO., LTD. LG (TIMOR SEA 06-102) LTD LG (YANTAI) INFORMATION & COMMUNICATION
TECH. LG ALINA ELECTONICS(LGERI) LG CHEM BRASIL INTERMEDICAO DE NEGOCIOS DO
SETOR QUIMICO LTDA. LG CHEM DISPLAY MATERIAL CO., LTD LG CHEM EUROPE GMBH LG CHEM INDUSTRIAL MATERIALS INC. LG CHEM POLAND SP. Z O. O. LG CHEM TAIWAN, LTD. LG CHEM(CHINA)INVESTMENT CO.,LTD. LG CHEM(NANJING) INFO & ELECTRONIC
MATERIALS CO. LTD LG CHEM(TIANJIN) ENGINEERING PLASTICS CO.,
LTD LG CHEMICAL AMERICA INC. LG CHEMICAL HONG KONG LTD. LG CHEMICAL INDIA PRIVATE LTD. LG CHEMICAL TRADING CO., LTD LG CHEMICAL(GUANGZHOU) ENGINEERING PLASTICS
CO.,LTD LG CNS AMERICA, INC LG CNS BRASIL SERVICOS DE T.I.LTDA LG CNS CHINA, INC LG CNS EUROPE B.V LG CNS GLOBAL PRIVATE LIMITED |
|
Affiliates-Overseas |
LG CNS JAPAN, INC LG CNS PHILIPINES, INC LG ELCTRONICS NORWAY AS LG ELECTONICS HUIZHOU LTD. LG ELECTRONICS (KUNSHAN) COMPUTER CO., LTD. LG ELECTRONICS (LEVANT) - JORDAN LG ELECTRONICS (NANJING) PLASMA CO., LTD LG ELECTRONICS (SHENYANG) INC.(LGESY) LG ELECTRONICS AFRICA LOGISTICS FZE LG ELECTRONICS ALAMABA, INC. (LGEAI) LG ELECTRONICS ALMATY KAZAK CO.,
LTD.(LGEAK) LG ELECTRONICS ARGENTINA S.A.(LGEAR) LG ELECTRONICS AUSTRALIA PTY., LTD. (LGEAP) LG ELECTRONICS AUSTRIA GMBH LG ELECTRONICS BENELUX SALES B.V. LG ELECTRONICS CANADA,INC. (LGECI) LG ELECTRONICS CHINA CO., LTD. (LGECH) LG ELECTRONICS COLOMBIA, LTDA.(LGECB) LG ELECTRONICS CZECH S.R.O. LG ELECTRONICS DA AMAZONIA LTDA (LGEAZ) LG ELECTRONICS DE SAO PAULO LTDA. (LGESP) LG ELECTRONICS DEUTSCHLAND.GMBH. (LGEDG) LG ELECTRONICS EGYPT CARIO S.A.E (LGEEC) LG ELECTRONICS EGYPT S.A.E. (LGEEG) LG ELECTRONICS ESPANA S.A. (LGEES) LG ELECTRONICS EUROPEAN HOLDINGS B.V. LG ELECTRONICS EUROPEAN LOGISTICS &
SERVICES B.V. LG ELECTRONICS EUROPEAN SHARED SERVICE
CENTER B.V. LG ELECTRONICS FRANCE S.A.R.L. LG ELECTRONICS GULF FZE (LGEGF) LG ELECTRONICS HELLAS S.A LG ELECTRONICS HK LTD.(LGEHK) LG ELECTRONICS INC. CHILE LIMITADA LG ELECTRONICS INDIA (PVT.) LTD. (LGEIL) LG ELECTRONICS ITALY S.P.A. (LGEIS) |
|
Affiliates-Overseas |
LG ELECTRONICS JAPAN INC. (LGEJP) LG ELECTRONICS JIT EUROPE B.V LG ELECTRONICS LATVIA LLC LG ELECTRONICS MAGYAR KFT. (LGEMK) LG ELECTRONICS MALAYSIA SDN. BHD.(LGEML) LG ELECTRONICS MEXICALI, S. A. DE C. V.
(LGEMX) LG ELECTRONICS MEXICO S.A. DE C.V (LGEMS) LG ELECTRONICS MIDDLE EAST CO., LTD. LG ELECTRONICS MLAWA SP.ZO.O (LGEMA) LG ELECTRONICS MOBILE RESEARCH U.S.A. LLC
(LGEMR) LG ELECTRONICS MOBILECOMM FRANCE S.A.S LG ELECTRONICS MOBLECOMM U.S.A.,
INC.(LGEMU) LG ELECTRONICS MONTERREY MEXICO S.A. DE
C.V. LG ELECTRONICS MOROCCO SARL(LGEMC) LG ELECTRONICS NANJING DISPLAY CO.,LTD LG ELECTRONICS(HANGZHOU) RECORDING MEDIA
CO., LTD LG ELECTRONICS NIGERIA LIMITED(LGENI) LG ELECTRONICS NORDIC AB LG ELECTRONICS OVERSEAS TRADING FZE LG ELECTRONICS PANAMA S.A. (LGEPS) LG ELECTRONICS PERU S.A. (LGEPR) LG ELECTRONICS PHILIPPINES, INC. (LGEPH) LG ELECTRONICS POLSKA SP.ZO.O (LGEPL) LG ELECTRONICS PORTUGAL S.A. LG ELECTRONICS QINHUANGDAO CO.,LTD(LGEQH) LG ELECTRONICS RAYNOSA, S.A.DE C.V(LGERS) LG ELECTRONICS ROMANIA S.R.L LG ELECTRONICS RUS.LLC |
|
Affiliates-Overseas |
LG ELECTRONICS RUS-MARKETING, LLC LG ELECTRONICS S.A.(PTY) LTD. (LGESA) LG ELECTRONICS SINGAPORE PTE LTD LG ELECTRONICS TAIWAN TAIPEI CO., LTD. LG ELECTRONICS THAILAND CO.,LTD.(LGETH) LG ELECTRONICS TIANJIN APPLIANCES CO., LTD. LG ELECTRONICS TICARET A.S LG ELECTRONICS UKLAINE LG ELECTRONICS UNITED KINGDOM LTD. (LGEUK) LG ELECTRONICS USA INC. (LGEUS) LG ELECTRONICS VIETNAM LTD. (LGESV) LG ELECTRONICS WALES LTD. (LGEWA) LG ELECTRONICS WROCLAW SP. ZO.O LG ELECTRONICS(CHINA) RESEARCH AND
DEVELOPMENT CENTER CO., LTD LG H&H TRADING(SHANGHAI) CO.LTD. LG HOLDINGS LTD. (LGHK) LG HOUSEHOLD & HEALTH CARE AMERICA, INC LG INNOTEK MEXICALI S.A. DE C.V LG INNOTEK POLAND SP. ZO.O. LG INNOTEK USA INC. LG INNOTEK YANTAI CO., LTD LG INTERNATIONAL AMERICA INC. LG INTERNATIONAL CORP.(SINGAPORE) PTE. LTD. LG INTERNATIONAL JAPAN LTD. LG INTERNATIONAL INVESTMENT (CANADA) LTD. LG INTERNATIONAL SAUDI LLC LG INTERNATIONAL (AUSTRALIA) PT'S, LTD. LG INTERNATIONAL(DEUTCHLAND) GMBH LG INTERNATIONAL(HK) LIMITED LG INTERNATIONAL (U.K.) LTD. LG LIFE SCIENCES INDIA PVT,LTD LG LIFE SCIENCES POLAND, LTD LG MICRON(FUJIAN) ELECTRONICS CO.,LTD LG MICRON (TAIWAN) LTD. LG MITR ELECTRONICS CO., LTD. (LGEMT) LG PHILIPS LCD AMERICA INC. LG PHILIPS LCD GERMANY GMBH LG PHILIPS LCD HONGKONG CO.,LTD LG PHILIPS LCD JAPAN CO.LTD. LG PHILIPS LCD NANJING CO. LTD LG.PHILIPS LCD SHENZEN CO., LTD. LG PHILIPS LCD TAIWAN CO. LTD. (LGPLT) |
|
Affiliates-Overseas |
LG PROPERTIES PTE. LTD. LG SOFT INDIA PVT LTD.(LGSI) LG SOLID SOURCE, LLC LG VINA CHEMICAL J/V COMPANY LG VINA COSMETICS LG.PHILIPS LCD GUANGZHOU CO., LTD.(LPLGZ) LG.PHILIPS LCD POLAND SP. Z O.O. LG.PHILIPS LCD SHANGHAI CO., LTD. LG-SHAKER CO.,LTD MONGOLIA RESOURCES INVESTMENT LIMITED NAKHODKA FEZ TELECOMMUNICATIONS
CO.LTD.(ROKOTEL) NANJING LG INTERNATIONAL VMI LTD.CO. NANJING LG PANDA APPLIANCES CO., LTD.
(LGEPN) NINGBO LG YONGXING CHEMICAL CO., LTD. PHILCO RESOURCES LIMITED PT LG CNS INDONESIA PT LG ELECTRONICS INDONESIA (LGEIN) PT. BATUBARA GLOBAL ENERGY PT. GOLDEN HYUNDAI MACHINERY(PT.GHM) PT. KIMCO ENERGY UTAMA PT. LG INNOTEK INDONESIA PT. TUTUI BATUBARA UTAMA QINGDAO LG INSPUR DIGITAL COMMUNICATION
CO., LTD. RESOURCES INVESTMENT (H.K) LIMITED SHANGHAI LG ELECTRONICS CO., LTD.
(LGESH) SILTRON AMERICA, INC. TAIZHOU LG ELECTRONIC REFRIGERATION
CO.LTD(LGETR) TIANJIN LG BOHAI CHEMICL CO.,LTD. TIANJIN LG DAGU CHEMICAL CO., LTD. TIANJIN LG NEW BUILDING MATERIALS CO., LTD. TRIVENI DIGITAL INC. V-ENS (M) SDN. BHD. ZENITH ELECTRONICS CO. (ZENITH) |
|
Overseas Office |
BEIJING REPRESENTATIVE OFFICE ROOM NO.1509 BUILDING "B" EAGLE
RUN PLAZA NO.26 XIAOYUN ROAD, CHAOYANG DISTRICTBEIJING 100061, CHINA TEL:+86-10-8458-3052/3 FAX:+86-10-8458-3055 LG INTERNATIONAL DO BRAZIL LTDA. AV. DR., CHUCRI, ZAIDAN, 940, 3O ANDAR
MARKET PLACE (TOWER II), SAO PAULO CEP 04583-110, SP, BRAZIL TEL:+55-11-2162-5610 FAX:+55-11-2162-5613 |
|
Subsidiary |
LG LIFE SCIENCES INDIA PVT. LTD. (100% held by the subject company) LG HOUSE, AB-3, COMMERCIAL COMPLEX,
SAFDARJUNG ENCLAVE, NEW DELHI-110 029, INDIA TEL:+91-11-2671-4004 FAX:+91-11-2671-3716 LG LIFE SCIENCES POLAND SP.Z.O.O (100% held by the subject company) UL. GRZYBOWSKA 80/82 00-844 WARSAW, POLAND TEL:+48-22-661-55-15 FAX:+48-22-651-55-13 LG LIFE SCIENCES (BEIJING) CO., LTD. |
|
Corporate Ownership |
LG CORPORATION(110111-0003543) |
|
Major Shareholders |
LG CORPORATION(110111-0003543) |
|
Cooperative Enterprise |
TAKEDA PHARMACEUTICAL COMPANY LIMITED.
(JAPAN) SUMMIT-AGRO EUROPE(SAE) (JAPAN) OSCIENT PHARMACEUTICALS CORP. (USA) ANADYS PHARMACEUTICALS, INC. (USA) GILEAD SCIENCE, INC.(USA) NOVAVAX(USA) -Brand Using License with LG CORPORATION(110111-0003543) |
(Activity &
Markets)
|
Sales/ Unit :Mil KRW |
2010 |
2009 |
2008 |
|
Export |
114,224 |
146,169 |
149,135 |
|
Domestic |
162,277 |
188,960 |
171,846 |
|
Others |
7,897 |
5,887 |
13,580 |
|
Total |
284,398 |
341,016 |
334,562 |
The Subject exports to Japan, USA and Europe.
|
Case No. |
Court |
Plaintiff(s)/
Creditor(s)/ Applicant(s) |
Defendant(s)/
Debtor(s)/ Respondent(s) |
Cause |
Amount (Million KRW) |
Status |
|
|
Seoul Central District Court |
- |
The Subject Company |
Claim for Compensation from Infringement of Patent |
550 |
1st round is proceeding. |
|
|
|
- |
The Subject Company |
Claim for Compensation |
1,920 |
2nd round is proceeding |
--
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.53.96 |
|
|
1 |
Rs.84.49 |
|
Euro |
1 |
Rs.72.23 |
INFORMATION DETAILS
|
Report
Prepared by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.